Post-stroke dysphagia PSD
Conditions
Interventions
Rehabilitation control group:Swallowing Rehabilitation
Experimental group:acupuncture
Healthy control group:None
Sponsors
Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for ischemic stroke patients with pseudobulbar paralysis: (1) Meet the diagnostic criteria for acute ischemic stroke in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 and the diagnostic criteria for dysphagia disorders (the diagnostic criteria for the Treatment of Stroke Patients: Identification and Treatment of dysphagia in the National Clinical Guidelines for Stroke written by the Scottish College Guidelines Collaboration Group); (2) Aged 18-80 years; (3) Functional oral feeding (FOIS) score 2-4; (4) 15 days <= duration <=180 days; (5) The infarct was located in the cerebral cortex and subcortical regions of the brain; (6) The patient or legal representative gives informed consent and signs the informed consent. 2. Inclusion criteria for health controls: (1) From community recruitment; (2) Gender and age matched with the experimental group; (3) No history of stroke diabetes hypertension hyperlipidemia coronary heart disease etc.; (4) No history of smoking or drinking; (5) The National Institute of Health Stroke Scale (NHISS) assessed the degree of neurological impairment <=1 score; (6) No responsible lesions were determined by brain CT or MRI.
Exclusion criteria
Exclusion criteria: 1. Patients with dysphagia disorder before the onset of the disease; 2. Suffering from other life-threatening serious diseases with an expected survival time of less than 3 months; 3. Unable to complete the study due to mental illness cognitive or emotional disorders;Patients with severe needle fainting intolerance; 4. Unable to complete the swallowing function assessment;Patients who are pregnant planning pregnancy or breastfeeding; 5. Patients who have participated in other drug clinical trials in the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Oral Intake Scale (FOIS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Amplitude of Low Frequency Fluctuation (ALFF);Patient-Reported Outcomes Assessment;Surface electromyography (sEMG);Regional homogeneity (ReHo);Swallowing-Related Quality of Life score (SWAL-QOL);National Institutes of Health Stroke Scale (NIHSS);Amplitude of low (ALFF); | — |
Countries
China
Contacts
Public ContactMurong Zhimiao
Hu'nan University of Chinese Medicine
Outcome results
None listed